Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Expert Opinion on Investigational Drugs
|
January 5, 2002
Botulinum toxin type B: a new injectable treatment for cervical dystonia
A Brashear
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Botulinum toxin type A: Exploring new indications
A Brashear
Seminars in Neurology
|
May 11, 2001
The botulinum toxins in the treatment of cervical dystonia
A Brashear
Journal of Neuro-Oncology
|
September 1, 1997
Focal dystonia after chemotherapy: a case series
A Brashear, E Siemers
Analytical Biochemistry
|
June 1, 1983
A spectrophotometric, enzymatic assay for D-3-hydroxybutyrate that is not dependent on hydrazine
A Brashear, G A Cook
Muscle & Nerve
|
January 1, 1996
The influence of the reference electrode on CMAP configuration: leg nerve observations and an alternative reference site
A Brashear, J C Kincaid
Applied and Environmental Microbiology
|
June 1, 1983
Inactivation of indigenous viruses in raw sludge by air drying
D A Brashear, R L Ward
The Journal of Biological Chemistry
|
September 25, 1989
A novel 58-kDa protein associates with the Golgi apparatus and microtubules
G S Bloom, T A Brashear
Applied and Environmental Microbiology
|
June 1, 1982
Comparison of methods for recovering indigenous viruses from raw wastewater sludge
D A Brashear, R L Ward
Neurology
|
February 24, 2001
The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials
M F Lew, A Brashear, S Factor
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Expert Opinion on Investigational Drugs
|
January 5, 2002
Botulinum toxin type B: a new injectable treatment for cervical dystonia
A Brashear
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Botulinum toxin type A: Exploring new indications
A Brashear
Seminars in Neurology
|
May 11, 2001
The botulinum toxins in the treatment of cervical dystonia
A Brashear
Journal of Neuro-Oncology
|
September 1, 1997
Focal dystonia after chemotherapy: a case series
A Brashear, E Siemers
Analytical Biochemistry
|
June 1, 1983
A spectrophotometric, enzymatic assay for D-3-hydroxybutyrate that is not dependent on hydrazine
A Brashear, G A Cook
Muscle & Nerve
|
January 1, 1996
The influence of the reference electrode on CMAP configuration: leg nerve observations and an alternative reference site
A Brashear, J C Kincaid
Applied and Environmental Microbiology
|
June 1, 1983
Inactivation of indigenous viruses in raw sludge by air drying
D A Brashear, R L Ward
The Journal of Biological Chemistry
|
September 25, 1989
A novel 58-kDa protein associates with the Golgi apparatus and microtubules
G S Bloom, T A Brashear
Applied and Environmental Microbiology
|
June 1, 1982
Comparison of methods for recovering indigenous viruses from raw wastewater sludge
D A Brashear, R L Ward
Neurology
|
February 24, 2001
The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials
M F Lew, A Brashear, S Factor
Page
of 5